{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:56:16Z","timestamp":1781718976660,"version":"3.54.5"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Allergy to\n                      <jats:italic>Hymenoptera<\/jats:italic>\n                      venom is one of the most frequent causes of anaphylaxis in adults. Conventional diagnostic approaches, including skin testing and measurement of allergen-specific IgE (sIgE) to venom extracts, do not always allow for precise identification of the culprit venom. This remains particularly challenging in patients with double-positive or inconclusive conventional test results, which may complicate the decision-making process regarding qualification for appropriate treatment. Component-resolved diagnostics (CRD) and the basophil activation test (BAT) may provide complementary information in such cases and aid in qualification for subcutaneous immunotherapy (SCIT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective registry-based cross-sectional study, 154 adults who had been evaluated for\n                      <jats:italic>Hymenoptera<\/jats:italic>\n                      venom allergy at the Military Institute of Medicine (Warsaw, Poland) between December 2023 and May 2025 were included. Patients were divided into three groups: not qualified for SCIT (n\u2009=\u200927), qualified for bee venom immunotherapy (n\u2009=\u200932), and qualified for wasp venom immunotherapy (n\u2009=\u200995). Serum sIgE to venom extracts and certain components (rApi m 1, m 2, m 3, m 5, m 10; rVes v 1, v 5) were measured. BAT was performed by flow cytometry assessing CD63 expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Moderate correlations were found between BAT results and sIgE to rApi m 1 (rho\u2009=\u20090.495; p\u2009&lt;\u20090.001) and rVes v 5 (rho\u2009=\u20090.456; p\u2009&lt;\u20090.001). No correlation was observed for rVes v 1, and negative correlations were noted between rApi m 1 and rVes v 5 in heterologous BAT responses. No statistically significant association was observed between the severity of previous sting reactions and BAT or sIgE parameters. However, due to limited subgroup sizes, these analyses were underpowered and the results should be interpreted as inconclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among the examined variables, the major components Api m 1 and Ves v 5 were the most strongly correlated with specific basophil activation in vitro. The combined use of CRD and BAT may support clinical assessment and facilitate decisions regarding immunotherapy qualification. Further prospective studies are warranted to assess the prognostic and clinical relevance of our findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350189","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:21:58Z","timestamp":1781716918000},"page":"e0350189","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between results of component-resolved diagnostics and basophil activation in Hymenoptera venom allergy: A registry-based cross-sectional study in adults"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2755-050X","authenticated-orcid":true,"given":"Krzysztof \u0141ukasz","family":"Piwowarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-5680","authenticated-orcid":true,"given":"Krzysztof","family":"K\u0142os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Chcia\u0142owski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Raniszewska-Borys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kwiecie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Kruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"pone.0350189.ref001","doi-asserted-by":"crossref","first-page":"180","DOI":"10.18176\/jiaci.0310","article-title":"Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice","volume":"29","author":"MB Bil\u00f2","year":"2019","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"pone.0350189.ref002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"GJ Sturm","year":"2018","journal-title":"Allergy"},{"issue":"2","key":"pone.0350189.ref003","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.iac.2007.03.008","article-title":"Insect sting anaphylaxis","volume":"27","author":"DBK Golden","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"pone.0350189.ref004","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","article-title":"Mastocytosis and insect venom allergy","volume":"10","author":"P Bonadonna","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"pone.0350189.ref005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11882-015-0527-z","article-title":"Anaphylaxis to insect venom allergens: role of molecular diagnostics","volume":"15","author":"M Ollert","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"pone.0350189.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pai.12563","article-title":"EAACI Molecular Allergology User\u2019s Guide","volume":"27","author":"PM Matricardi","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"pone.0350189.ref007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40629-017-0014-2","article-title":"Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics","volume":"26","author":"T Jakob","year":"2017","journal-title":"Allergo J Int"},{"issue":"4","key":"pone.0350189.ref008","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000348500","article-title":"Clinical routine utility of basophil activation testing for diagnosis of hymenoptera-allergic patients with emphasis on individuals with negative venom-specific IgE antibodies","volume":"161","author":"P Koro\u0161ec","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"pone.0350189.ref009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2012.02.008","article-title":"Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants","volume":"130","author":"B Eberlein","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"pone.0350189.ref010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/02770906609106941","article-title":"Diagnosis and treatment of insect sensitivity","volume":"3","author":"HL Mueller","year":"1966","journal-title":"J Asthma Res"},{"key":"pone.0350189.ref011","unstructured":"WHO\/IUIS Allergen Nomenclature Sub-Committee. Allergen Nomenclature. Accessed 2026 Mar 7. Available from: https:\/\/allergen.org\/"},{"key":"pone.0350189.ref012","unstructured":"The jamovi project. jamovi (Version 2.3) [Computer software]. 2022. Available from: https:\/\/www.jamovi.org"},{"key":"pone.0350189.ref013","unstructured":"R Core Team. R: A language and environment for statistical computing. Version 4.1 [Computer software]. 2021. Available from: https:\/\/cran.r-project.org"},{"key":"pone.0350189.ref014","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13854","article-title":"EAACI Molecular Allergology User\u2019s Guide 2.0","volume":"34","author":"S Dramburg","year":"2023","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"pone.0350189.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199250","article-title":"The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosis","volume":"13","author":"P Gattinger","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"pone.0350189.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108619","article-title":"Basophil activation test using recombinant allergens: highly specific diagnostic method complementing routine tests in wasp venom allergy","volume":"9","author":"L Balzer","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"pone.0350189.ref017","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaip.2025.04.008","article-title":"Diagnostic utility of biomarkers in anaphylaxis: a systematic review and meta-analysis","volume":"13","author":"R Khalaf","year":"2025","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:22:07Z","timestamp":1781716927000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350189"}},"subtitle":[],"editor":[{"given":"Petr","family":"Heneberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350189","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}